Epinephrine Global Market Demand Analysis, Manufacturers Share, Regions, Risk Analysis, Driving Forces and Application, Forecast To 2033 | Sanofi SA, Viatris Inc., Lincoln Medical Ltd., Kaleo Inc., Gland Pharma Limited

The epinephrine market size has grown rapidly in recent years. It will grow from $2.44 billion in 2023 to $2.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to anaphylaxis incidence, regulatory framework, increased allergies, patient education, improved accessibility..

The epinephrine market size is expected to see strong growth in the next few years. It will grow to $3.82 billion in 2028 at a compound annual growth rate (CAGR) of 9.2%. The growth in the forecast period can be attributed to rising allergy rates, expanded access initiatives, awareness campaigns, emerging markets, customized epinephrine delivery systems.. Major trends in the forecast period include integration of smart devices, enhanced education and awareness programs, global expansion of epinephrine access, regulatory emphasis on product safety, collaborations for research and development..

Market Overview -
Epinephrine, also known as adrenaline, is a hormone and neurotransmitter used for life-threatening allergic reaction treatment spurred by foods, medicines, latex, insect bites or stings, and other reactions treated with epinephrine injections along with emergency medical treatment.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=9967&type=smp

Respiratory Health Rise Fueling Growth In The Epinephrine Market
The increase in the prevalence of chronic respiratory diseases is expected to propel the growth of the epinephrine market going forward. Chronic respiratory diseases refer to medical condition that affects the lungs and airways of the human body's respiratory system and has the potential to contract an infection or develop a disease, which can lead to a number of complications. Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis are increasing due to the prevalence of air pollution and harmful environmental, occupational, and behavioral inhalation exposures. Epinephrine is a key medication used in the treatment of severe asthma attacks and anaphylactic reactions, which can cause respiratory distress and potentially life-threatening complications. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . As the prevalence of chronic respiratory diseases continues to increase, the demand for epinephrine is also expected to grow.

Competitive Landscape -
Major companies operating in the epinephrine market report are ALK-Abelló A/S, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Mylan NV, Amneal Pharmaceuticals Inc., Bausch Health Companies Inc., Abbott Laboratories, Sanofi SA, Viatris Inc., Lincoln Medical Ltd., Kaleo Inc., Gland Pharma Limited, Adamis Pharmaceuticals Corporation, Harvest Pharmaceuticals Inc., Merit Pharmaceutical, Hospira, Inc., Antares Pharma Inc., Bausch & Lomb Incorporated, Novartis AG, Grand Pharma (China) Co. Ltd., Impax Laboratories LLC, Sandoz International GmbH, Tianjin Jinyao Group Co. Ltd., GlaxoSmithKline plc, Amphastar Pharmaceuticals Inc., Par Sterile Products LLC, Amedra Pharmaceuticals LLC, Crossject SA, Halozyme Therapeutics Inc .

Innovative Solutions With Advancements In Epinephrine Delivery Systems
Product innovation is a key trend gaining popularity in the epinephrine market. Major companies operating in the epinephrine market are involved in developing new and improved advanced products, such as auto-injectors or advanced injections, to improve convenience of consumption and sustain their position in the market. In September 2021, Baxter International Inc., a US-based healthcare company, launched Premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine) after getting approved by the US Food and Drug Administration (FDA). Norepinephrine bitartrate is a convenient formulation of norepinephrine manufactured by the pharmaceutical company in dosages of 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL). Adult patients with severe, acute hypotension are prescribed norepinephrine medication to raise blood pressure.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/epinephrine-global-market-report

Key Segments -
The epinephrine market covered in this report is segmented -
1) By Type: Prefilled Syringe, Auto-injector, Ampoules and Vials
2) By Application: Anaphylaxis, Cardiac Arrest, Superficial Bleeding, Respiratory Disorders, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.